TickerFacts.

MaxCyte, Inc. (MXCT): Net Income

Annual figures by period end, from SEC filings.

-$44.63M
Year ended 2025-12-31
-$35.64M
Trailing 12 months to 2026-06-30
2019-12-31: -$12.89M2020-12-31: -$11.82M2021-12-31: -$19.08M2022-12-31: -$23.57M2023-12-31: -$37.92M2024-12-31: -$41.05M2025-12-31: -$44.63M-$44.63M
2019-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$44.63Mn/m2026-03-25, From 2025-01-01
2024-12-31-$41.05Mn/m2026-03-25, From 2024-01-01
2023-12-31-$37.92Mn/m2025-03-11, From 2023-01-01
2022-12-31-$23.57Mn/m2024-03-12, From 2022-01-01
2021-12-31-$19.08Mn/m2023-03-15, From 2021-01-01
2020-12-31-$11.82Mn/m2022-03-22, From 2020-01-01
2019-12-31-$12.89Mn/a2022-03-22, From 2019-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
MaxCyte, Inc. (MXCT)2025-12-31-$44.63Mn/m
OmniAb, Inc. (OABI)2025-12-31-$64.78Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$12.43Mn/m
NRC Health (NRC)2025-12-31$11.60M-53.2%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$14.91Mn/m
Absci Corp (ABSI)2025-12-31-$115.18Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$10.49Mn/m
OneMedNet Corp (ONMD)2025-12-31-$2.80Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$451.12M+11.6%

Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗